Proposed FDA Guidance for Industry #256
Public Affairs
•
50m
Download Handouts: https://bit.ly/2S7mPmm
Link to Comment: https://www.regulations.gov/comment?D=FDA-2018-D-4533-0001
Clinical Compounding Pharmacist Matt Martin, PharmD, and Chris Simmons, RPh, Vice President of Creative Development, host an informational webinar to discuss the proposed FDA Guidance for Industry #256, “Compounding Animal Drugs from Bulk Drug Substances.” They will give a general overview and point out some specific concerns pertaining to both pharmacists and veterinarians. They will also explain how pharmacists and veterinarians can submit comments to the FDA. There will be a question-and-answer period at the end of the webinar.
Up Next in Public Affairs
-
USP 795/797: Reviewing the New Propos...
Download Handout: https://bit.ly/3p0RHaw
USP has released their new revisions to chapters 795 and 797. Join us for a conversation highlighting the key themes, specific changes and new additions to these USP chapters that are highly influential to how you serve your patients. PCCA Vice President ...
-
Vet GFI 256: Coming into Compliance W...
Download Handout:
https://bit.ly/3JD5U5YIn advance of the April 1, 2023, enforcement date for the new animal compounding guidance from FDA, APC and PCCA are partnering to offer a CE webinar aimed at helping you bring your animal compounding operations into compliance – and to make sure the vete...
-
July 2017 House Appropriations Commit...
July 2017 House Appropriations Committee Meeting
